Sutro Biopharma
STRO
$3.94
Share price
5.35%
Change (1 day)
-13.97%
Change (1 year)
Categories
P/S ratio for Sutro Biopharma (STRO)
P/S ratio as of May 2024 (TTM): 1.87
According to Sutro Biopharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.87134. At the end of 2023 the company had a P/S ratio of 1.70.
P/S ratio history for Sutro Biopharma from 2018 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.70 | -75.18% |
| 2022 | 6.85 | -38.49% |
| 2021 | 11.1 | -52.09% |
| 2020 | 23.2 | 291.05% |
| 2019 | 5.95 | 10.84% |
| 2018 | 5.36 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 1.03 | -45.22% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 92.5 | 4,842.91% | 🇺🇸 USA |